Detalhe da pesquisa
1.
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.
Immunity
; 51(5): 915-929.e7, 2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732167
2.
Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 Adjuvant.
Bioconjug Chem
; 27(10): 2372-2385, 2016 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27583777
3.
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial.
Lancet Microbe
; 5(6): e581-e593, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38761816
4.
Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine.
Front Immunol
; 12: 772864, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34956199
5.
Monitoring HIV vaccine trial participants for primary infection: studies in the SIV/macaque model.
AIDS
; 23(12): 1453-60, 2009 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-19550289